Optimax Holdings Bhd (Optimax), a private eye specialist service provider with 25 years history, launched its prospectus for its listing on the ACE Market of Bursa Malaysia on 15 July at the Four Seasons Hotel Kuala Lumpur.
Optimax was founded in 1995 by Dato’ Tan Boon Hock. He first started with a single centre in Taman Tun Dr Ismail in Kuala Lumpur, expanding to 13 eye specialist centres to date. The centres include one specialist hospital, 11 ambulatory care centres and one specialist clinic. These facilities spread across the Northern, Central and Southern regions of Peninsular Malaysia as well as East Malaysia.
In a statement, the company announced that Affin Hwang Investment Bank Bhd will underwrite 17.5 million new shares under the initial public offering (IPO). The IPO entails the public issue of 70 million IPO shares, issued at the price of RM0.30 per share.
A total of 13.5 million shares will be made available for public, with four million shares reserved by Optimax’s eligible directors and employees. The balance of 52.5 million shares will be placed to Malaysian institutional and selected investors.
Envisioning the future
With gross proceeds from the IPO expected to raise RM21 million, Optimax plans to channel funds towards capital expenditure, repayment of borrowings, listing expenses and working capital.
“Our immediate plans will be to expand our ambulatory care centre network in the Central region of Peninsular Malaysia. This addresses the potential needs of urban communities in this densely populated region. Part of the proceeds from the IPO will go towards equipping our Seremban specialist centre and purchasing the property to convert this centre to an ambulatory care centre. We are also purchasing new equipment and tools for existing centres as part of our plans to upgrade the equipment as well as increase our services and expand our capacity,” shares Sandy Tan, CEO of Optimax Holdings Berhad.
Equipped with a team of specialists comprising 18 eye surgeons and 33 optometrists, Optimax’s services may be broadly categorised into four major groups. The first is refractive surgery which includes laser vision correction and implant vision correction. Second, treatment of eye diseases and disorders inclusive of cataract surgery and other eye medical treatments. Third, consultation and dispensary services comprising doctor consultation and medication and lastly, oculoplastic surgical procedures.
For more information, visit optimax2u.com